|
MedKoo's collection
Anticancer agents in preclinical studies
This page is being updated
on daily basis, please come to visit very often
Code# ||
Name
401002 ||
A83-02 (ALK inhibitor)
401010
||
A-443654 (AKT
inhibitor)
401012
|| A-674563
(AKT inhibitor)
401018 ||
A-769662 (AMPK
activator)
406213 ||
AAE871 (FLT-3 inhibitor)
406202 ||
AC710 (PDGFR inhibitor)
406221 || Actinonin
(HDAC inhibitor)
406214 || AFG206 (FLT-3 inhibitor)
406215 ||
AFG210 (FLT-3 inhibitor)
406184 ||
AG-012986 (CDK inhibitor)
406233 ||
AG-1024 (IGF-IR inhibitor)
406210 ||
AG1295 (PDGFR inhibitor; FLT-3 inhibitor)
406209 ||
AG1296 (PDGFR inhibitor; FLT-3 inhibitor)
401019
||
AG-1478
(EGFR inhibitor)
401020 ||
AG-14361 (PARP
Inhibitor)
406216 || AHL196 (FLT-3 inhibitor)
406165 ||
AKI-001 (Aurora inhibitor)
406139
||
AMD3465 (CXCR4
antagonist)
401025 ||
AMP423
(cyanoaziridine-derivative)
406113 ||
AN-7 (HDAC
inhibitor)
406169 ||
AP23464 (Bcr-Abl
inhibitor)
406170 ||
AP23846
(Bcr-Abl
inhibitor)
406171 ||
AP23848
(Bcr-Abl
inhibitor)
406222 ||
Apicidin (HDAC inhibitor)
406237 ||
AS601245 (JNK inhibitor)
406211 ||
AST487 (NVP-AST487) (RET kinase inhibitor, FLT-3 inhibitor)
401070
||
AST-1306 ((EGFR inhibitor)
401100 ||
AT7867
(AKT
inhibitor)
406218 ||
ATH686 (FLT-3 inhibitor)
406217 || AUZ454 (FLT-3 inhibitor)
406251 ||
AZ-505 (SMYD2 inhibitor)
406110
||
AZ-628 (Raf
inhibitor)
406191 ||
AZ-960 (JAK2 inhibitor)
406239 ||
AZ-3146 (Mps1 inhibitor; KSP inhibitor)
401120
|| AZD2932
(VEGFR-2 and PDGFR inhibitor)
406260 ||
AZD-8186 (PI3Kβ inhibitor)
406177 ||
BAY 61-3606
(Syk inhibitor)
406223 || BE 16627B (HDAC inhibitor,
metalloproteinase inhibitor)
401140 ||
BIX02188
(MEK inhibitor)
401150
||
BIX02189 (MEK
inhibitor)
406178 ||
BMI-1026 (CDK inhibitor)
401152
||
BMS-265246
(CDK1/CDK2 inhibitor)
406234 || BMS-317180
(growth hormone secretagogue; IGF-IR inhibitor)
406235 || BMS-554417
(IGF-IR inhibitor)
406148
||
BMS-690154 (pan
HER/VEGFR2 receptor tyrosine kinase inhibitor)
401155 ||
BMS-794833
(Met and VEGFR inhibitor)
401156
|| BRN-103 (VEGFR inhibitor)
406179 ||
BS-181 (CDK inhibitor)
401158 ||
BX795 (
PDK1 inhibitor)
401161 ||
BPR1J-097 (FLT3
kinase inhibitor)
406243 ||
BTB-1 (KSP inhibitor)
401210 ||
CCT-137690 (pan-Aurora kinase
inhibitor)
401212 ||
CCT128930
(AKT
inhibitor)
406162 ||
CCT129202 (Aurora kinase inhibitor)
406227 ||
CCT018159
(Hsp90 inhibitor)
402210 ||
CDKI-83 (CDK9
inhibitor)
406203 ||
CEP-5214 (VEGFR inhibitor
401213
||
CEP-28122 (Anaplastic
Lymphoma Kinase inhibitor)
406123
||
CEP-33779 (JAK2
inhibitor)
401218 ||
CG200745 (HDAC
inhibitor)
406100
||
CGI560 (BTK
inhibitor)
406012
||
CGI1746
(BTK inhibitor)
406204 ||
CGP52421 (FLT-3 inhibitor)
401214 ||
CH5424802 (ALK
inhibitor)
401220
||
Chrysophanic
acid (EGFR/mTOR
pathway inhibitor)
406199 ||
CInQ-03 (MEK inhibitor)
406238 ||
CK0106023 (KSP inhibitor)
406106 ||
CL-387785
(EGFR inhibitor)
406107 ||
CNX-744 (BTK inhibitor)
406246 ||
CNX-1351 (PI3K alpha inhibitor)
406247 ||
CX-6258 (PIM-1 inhibitor)
401235 ||
Cyclopamine
(Hedgehog inhibitor)
406176 ||
Degrasyn (BCR-ABL inhibitor)
401430 ||
Droxinostat (HDAC
inhibitor)
406259 ||
E-7438 (EZH2 inhibitor)
410440 || EHT
6706 (microtubule-disrupting agent )
406151
|| Elliptinium
acetate
(topoisomerase II inhibitor)
406244 ||
EPZ004777 (DOT1L Inhibitor)
406145
|| ETP-46321
(PI3K inhibitor)
406207 ||
FI-700 (FLT3 inhibitor)
406108
|| FIIN-1
(FGFR inhibitor)
406146
|| FLLL31
(Stat3 inhibitor)
406111
|| FLLL32 (Stat3
inhibitor)
406200 ||
G-573 (MEK inhibitor)
406101
|| GDC-0834
(BTK inhibitor)
401460 || GDC-0837
(BTK inhibitor)
401470 ||
GDC-0879 (B-Raf
Inhibitor)
406141
||
GENZ-123346
(GCS inhibitor)
406250 ||
GNE-555 (mTOT inhibitor)
406206 ||
Go6976 (PCK inhibitor, FLT-3 inhibitor)
406136
||
GO6983 (PKC
inhibitor)
401473
|| GNF-2
(BCR-ABL Allosteric inhibitor)
406228 ||
GSK126 (EZH2 methyltransferase
inhibitor)
406255 ||
GSK-3787 (PPARδ antagonist)
401475
||
GSK1838705A (
IGF-IR and IR inhibitor)
401480 ||
GSK-1904529a
(IGF-1R
Inhibitor)
406156 ||
GSK2334470 (PDK1
inhibitor)
406230 ||
GSK2656157 (PERK
kinase inhibitor)
406205 || GTP-14564 (FLT-3 inhibitor)
401482 ||
GW2580 (cFMS kinase
inhibitor)
401483 ||
GW5074 (c-Raf inhibitor)
406131
||
GW6471 (PRAP
inhibitor)
406132
||
GW9662 (PRAP
inhibitor)
401488 ||
GW788388 (TGF-beta
inhibitor)
406153
||
Hepsulfam (alkylsulfonate
alkylating agent)
401510 ||
HM30181
(MDR1 inhibitor)
406154
||
I-BET151 (GSK1210151A) (BET
bromodomain inhibitor)
406155
||
IC-87114 (PI3K
inhibitor)
406192 ||
INCB16562
(JAK2 inhibitor)
402501
||
Indimitecan
(LMP776) (Topoisomerase I inhbitor)
402502
||
Indotecan (LMP400)
(Topoisomerase I inhbitor)
401512 ||
IOX2 (HIF inhibitor)
406157 ||
ISC-4 (AKT inhibitor)
406104
||
JH295 (Nek2 irreversible Nek2
inhibitor)
406201 ||
JNJ-28312141
(CSF1R inhibitor / FLT3 inhibitor)
406161 ||
JNJ-7706621 (Aurora
kinase inhibitor)
401515 ||
KCN1 ( HIF inhibitor)
401517
||
Ki23057 (FGFR2
inhibitor)
401520 ||
KP372-1 (Akt inhibitor)
406114
||
KRC-108 (multi-kinase inhibitor)
406218 ||
KRN383 (FLT-3 inhibitor)
401525
||
KU0063794 ((mTOR
inhibitor)
406125
||
Largazole (HDAC
inhibitor)
406185 ||
LBW242 (IAP inhibitor)
406138
||
LDN193189 (ALK
inhibitor)
401531
||
LFM-A13 (Btk and
Polo-like kinase inhibitor)
406112
||
LLL12 (Stat3
inhibitor)
406115
||
LQB-118
401535 ||
LW6 (HIF-1α
inhibitor)
401540 ||
LY475776
(P-glycoprotein inhibitors)
401550 ||
LY2109761 (TGF-β
receptor I kinase inhibitor)
406137
||
LY364947 (TGF-β
type-I receptor
inhibitor)
401552
||
Migrastatin
(migration inhibitor)
406251 ||
MK-8745 (Aurora A
inhibitor)
401554 ||
MLN0905 (PLK1
Inhibitor)
401555
|| MNBA (4-methyl-3-nitro-benzoic acid)
(migration inhibitor)
406240 ||
Monastrol
(KSP inhibitor, Kinesin Eg5 inhibitor)
406119
||
MT477 (PKC-alpha
inhibitor)
401560 ||
Mubritinib (TAK-165)
(EGFR inhibitor)
406187
|| NLCQ-1 (bioreductive drug)
406144
||
NVP-231 (Cerk inhibitor)
401562
||
NVP-BEP800 (BEP800) (Hsp90 inhibitor)
406172 ||
NVP-BHG712 (EphB4 kinase inhibitor, BCR-ABL
inhibitor)
406124
||
NVP-BSK508 (JAK inhibitor)
406140
||
OGT2378 (GCS
inhibitor; Glucosyl Ceramide Synthase Inhibitor)
406180 ||
Olomoucine
(CDK inhibitor)
406166 ||
OM-137 (Aurora kinase inhibitor)
401565 ||
OSI-420 (CP-473420)
( EGFR inhibitor )
401680
||
PD98059 (MEK
inhibitor; MAP kinase inhibitor)
406163 ||
PD-166285
( tyrosine kinase inhibitor)
406174 ||
PD166326
(BCR-ABL inhibitor)
406105
||
PD-168393 (pan
erbB inhibitor)
406164 ||
PD-173955 (src tyrosine kinase
inhibitor)
406175
|| PD180970 (BCR-ABL inhibitor)
406196 ||
PD184161
(MEK inhibitor)
406195 ||
PD318088 (MEK inhibitor)
401685 ||
PF-AKT400
(Akt inhibitor)
406142
||
PF-543
(sphingosine kinase-1 inhibitor)
406249 ||
PF-03671148 (ALK5
inhibitor)
406212 ||
PF-04880594
(RAF inhibitor)
406248 ||
PF-05139962 (mTOR
inhibitor)
401691
||
PF-4942847 (HSP90
inhibitor)
406261 ||
PFI-1 (BET bromodomain inhibitor)
406126
|| PF
573228 (FAK inhibitor)
406160 ||
PHA-680632
(Aurora kinase inhibitor)
406181 ||
PHA-767491
(CDK inhibitor)
401705
||
PHT-427 (Akt inhibitor)
406128
|| PJ34
(PARP inhibitor)
406256 ||
PP1 (Src kinase inhibitor)
401706
|| PP2
(Syk inhibitor)
401708
||
PP121
(multiple tyrosine kinase inhibitor)
401710 ||
PP-242 (mTOR inhibitor)
406133
||
Purmorphamine
(Hedgehog agonist)
406158 ||
PX-316 (AKT inhibitor)
401780
||
R112 (Syk inhibitor)
401810 ||
R428
(Axl Kinase inhibitor)
406188
|| RB-90740 (bioreductive drug)
406245 ||
Piperlongumine (ROS enhancer)
406103
||
RN486
(BTK inhibitor)
406120
||
RKS-262 (cyclin/CDK
inhibitor)
406182 ||
RO-3306 (CDK inhibitor)
406224 ||
RO314724 (HDAC inhibitor)
406198 ||
RO5068760
(MEK inhibitor)
401901
||
SB202580 (MEK
inhibitor; MAP kinase inhibitor)
401903 ||
SB-216763
(glycogen synthase kinase-3 (GSK-3) inhibitor)
401910
||
SB-431542 (TGF-beta receptor inhibitor, ALK inhibitor)
406135 ||
SB505124
(TGF-beta receptor inhibitor, ALK inhibitor)
406109
||
SB-590885 (Raf
inhibitor)
406225
|| SC-44463 (HDAC inhibitor, MMP inhibitor)
406167 || SCH-1473759
(Aurora kinase inhibitor)
401913
||
SG2057
406159
|| SH-5 (AKT inhibitor)
401915
||
SIM010603
(multi-targets receptor tyrosine kinases inhibitor)
406130
||
Sirtinol (HDAC
inhibitor,
SIRT inhibitor)
401950
|| SK1071 (anti-metastasis agent)
401970
||
SKLB610 (VEGFR
inhibitor)
401980
||
SKLB1002 (VEGF
receptor 2 signaling inhibitor)
401920
||
SL0101
(RSK inhibitor)
406197 ||
SL327 (MEK inhibitor)
406186
|| SN-23862 (bioreductive drug)
406117
||
SN-28049 (topoisomerase
inhibitor)
406226 ||
SNX-7081
(Hsp90 inhibitor)
406236 ||
SP-600125 (JNK inhibitor)
402110
|| SRT1720
(activator of the sirtuin subtype SIRT1)
402120
|| ST1926
(orally active retinoid-related molecule)
406219
||
SU5614
(FLT-3
inhibitor)
402140
|| SU6656 (Src
kinase inhibitor)
402150
|| SU11274
(Met tyrosine kinase inhibitor)
406220
||
SU11657 (FLT-3
inhibitor)
406242
||
Syntelin (CENP-E inhibitor)
406129 ||
T0070907 (PPARgamma
antagonist)
406127
|| TAE226
(NVP-TAE226) (FAK inhibitor)
406208
|| TDZD-8 (GSK-3beta
inhibitor, FLT-3 inhibitor)
406184
|| Tenovin-1 (p53 activator)
406147 ||
TG100435 (Src kinase
inhibitor)
403010
||
TG100713 (PI3K inhibitor)
406190
|| TG101209 (JAK inhibitor)
406252
|| TIC-10 (TRAIL gene activator)
936091-14-4
403550 ||
Tubastatin-A (HDAC6 inhibitor)
404210 ||
U0126 (MEK inhibitor; MAP kinase inhibitor)
406241 ||
UA62784 (CENP-E inhibitor)
406254
|| UNC-0631
(histone
methyltransferase inhibitor)
404910 ||
UNC-0638 (histone
methyltransferase inhibitor)
406253
|| UNC-0646
(histone
methyltransferase inhibitor)
406257 ||
VE-821 (ATR inhibitor)
406258 ||
VE-822
(ATR inhibitor)
406143
|| VPC03090 (Sphingosine-1-Phosphate Receptor
Inhibitor)
406121
||
WHI-P154
(JAK3 inhibitor)
405110 ||
WK-X-34
(P-glycoprotein inhibitors)
406194 ||
WP-1034 (JAK2 inhibitor)
406122
||
WP1066 ( Stat3 inhibitor, JAK2 inhibitor)
405150
||
WYE-354 (mTOR
inhibitor)
405250
||
WZ811 (CXCR4
antagonist)
406134
||
XAV-939 (Wnt
β-catenin-mediated transcription inhibitor)
406229 ||
XL344 (mTOR inhibitor)
405550
||
XR9051
(P-glycoprotein inhibitors)
406116
||
YC-1 (HIF-1α inhibitor;
guanylyl cyclase activator)
406168 ||
YC-137 (BCL-2 inhibitor)
405580
||
ZM306416
(VEGFR inhibitor)
405610
||
ZM323881
(VEGFR-2/KDR inhibitor)
405650
||
ZM336372 (Raf-1
activator)
|
